Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Organovo Holdings Inc ONVO

Healthcare Biotechnology
Organovo Holdings, Inc. is a biotechnology company that focuses on building high fidelity, three-dimensional (3D) tissues that recapitulate various aspects of human disease. The Company uses these models to identify gene targets responsible for driving the disease and intends to initiate drug discovery programs around these validated targets. It is initially focusing on the intestine and has... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:ONVO)

Organovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to Placebo

GlobeNewswire April 15, 2024

Organovo Presents FXR314 3D Human Tissue Model Findings That Show Improved Epithelial Barrier Function and Fibrosis Reduction at Crohn's and Colitis Congress

GlobeNewswire January 25, 2024

Organovo To Present FXR314 IBD 3D Model Findings at Upcoming Crohn's and Colitis Congress

GlobeNewswire January 9, 2024

Organovo Provides Timing for Release of FXR314 Phase 2 NASH Results

GlobeNewswire December 6, 2023

CORRECTION - Organovo Highlights FXR314 Combination Therapy Potential and Plan

GlobeNewswire November 13, 2023

Organovo Highlights FXR314 Combination Therapy Potential and Plan

GlobeNewswire November 8, 2023

Organovo to Participate in the H.C. Wainwright Global Investment Conference

GlobeNewswire September 8, 2023

Organovo Advances Clinical Timelines for FXR314 and Provides Updates on NASH Phase 2 Data

GlobeNewswire August 23, 2023

Organovo Announces FXR Program

GlobeNewswire March 21, 2023
View More News ››

Opinion & Analysis (NDAQ:ONVO)

3D printing is a manufacturing game-changer

Richard (Rick) Mills November 15, 2019

Cutting-edge devices and diagnostics deliver drugs and profits: Cantor Fitzgerald's Caroline Corner

George S. Mack July 31, 2015

The Calandra Report: More biotech, Bitterroot, CTIX, BCRX, CUR and more

Thom Calandra January 14, 2014
View More Opinion ››

Bullboard Posts (NDAQ:ONVO)

Why Organovo Stock Is Up Today | Benzinga

BREAKING NEWS: $ONVO Why Organovo Stock Is Up Today | BenzingaOrganovo Holdings, Inc. (NASDAQ:ONVO) shares are trading higher Monday...
whytestocks - April 15, 2024

ONVO....The Perfect Storm?

Go ahead ....I dare ya ; ) A positive News Released this a.m with an S-1 filed and Effective EDGAR Entity Landing Page (sec.gov)
Iseneschal - April 15, 2024

adding more shares here today

using dollar cost averaging for this one,so glta.
coolfooldumbguy - May 31, 2019

it's a buy today for me

at the 75 cent mark,so glta.
coolfooldumbguy - May 30, 2019

RE:and then they were 2

my god. since 2015... hope you've cash in many times... have you looked at its charts?  It might take another long run before...
alphatradr - June 6, 2018

RE:ONVO RSP Long term hold

remains a long shot but what a long shot it is .....good luck Dmaster
dmastercard - January 29, 2018
View more Bullboard ››

Theralase Technologies Inc.

Theralase Technologies Inc.

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research ...
View More »